Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
NCT ID: NCT00162357
Last Updated: 2011-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
106 participants
INTERVENTIONAL
2004-04-30
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
NCT03049657
Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
NCT02098876
An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
NCT01638507
Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent
NCT01012583
Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)
NCT02060357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technetium Tc99m Sestamibi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to perform exercise or pharmacologic stress test.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lantheus Medical Imaging
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lantheus Medical Imaging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qi Zhu, MD
Role: STUDY_DIRECTOR
Lantheus Medical Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Hartford, Connecticut, United States
Local Institution
Waterbury, Connecticut, United States
Local Institution
Grand Rapids, Michigan, United States
Local Institution
Roslyn, New York, United States
Local Institution
Burlington, Vermont, United States
Local Institution
Roanoke, Virginia, United States
Local Institution
Wausau, Wisconsin, United States
Local Institution
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARDIOLITE-406
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.